Deferred royalty obligation related to the sale of future royalties
239,064
229,105
219,536
209,878
Other non-current liabilities
1,694
1,694
1,694
1,694
Total liabilities
297,779
308,875
306,282
296,926
Common stock, 0.001 par value - 300,000,000 shares authorized as of june 30, 2026 and december 31, 2025 16,576,205 and 8,584,309 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
17
17
9
85
Additional paid-in-capital
951,696
949,636
845,475
843,807
Accumulated other comprehensive (loss) income
-58
-101
19
33
Accumulated deficit
-1,054,972
-1,016,439
-977,955
-931,193
Total stockholders' deficit
-103,317
-66,887
-132,452
-87,268
Total liabilities and stockholders' deficit
194,462
241,988
173,830
209,658
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.